Tyler KennedyScientist, Gene Delivery Process and Analytical Development at Bristol Myers SquibbSpeaker
Profile
Tyler Kennedy is a Scientist in Gene Delivery Process and Analytical Development (GDPAD) at Bristol Myers Squibb where he is currently a downstream program lead focused on pre-clinical AAV process development, scale-up, and process transfer. Over his six years in GDPAD, Tyler and his team have developed purification strategies for both LVV and AAV programs, and successfully scaled and transferred these processes into GMP facilities. Tyler holds a Bachelor of Science in chemistry from the University of Washington and has spent 13 years in downstream process development.
Agenda Sessions
From a bench-scale rAAV platform process to GMP manufacturing: a look at how Tangential Flow Filtration (TFF) robustness and scaling impact successful process transfer
, 4:00pmView SessionFrom a bench-scale rAAV platform process to GMP manufacturing: a look at how Tangential Flow Filtration (TFF) robustness and scaling impact successful process transfer
, 4:00pmView Session